Klara Klein
Klara Klein is a researcher at the University of North Carolina's School of Medicine. She has been involved in groundbreaking studies exploring the effects of semaglutide, a medication originally developed for type 2 diabetes, on alcohol consumption and cravings. Her recent work suggests that semaglutide may have the potential to aid in treating alcohol use disorders, highlighting the need for further research to understand its efficacy and safety in this context.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Ukraine:
Klara Klein is a co-author of the study discussing the effects of the medication on alcohol consumption.
8
Canada:
Klara Klein is the study leader who reported on the potential of semaglutide for treating alcohol use disorder.
8
United Kingdom:
Klara Klein is the senior author of the study suggesting the potential of semaglutide for treating alcohol use disorder.
8
Slovenia:
Klara Klein from the University of North Carolina stated that the data shows the potential of semaglutide and similar drugs to fill the treatment gap for alcohol use disorders.
8